Altshuler Shaham LTD Mannkind Corp Transaction History

Altshuler Shaham LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.45 $105,819 - $159,755	-29,313 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$3.14 - $6.14 $50,362 - $98,479	16,039 Added 120.83%	29,313 $115,000
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $23,760 - $53,626	13,274 New	13,274 $42,000
Q1 2018 May 15, 2018	SELL	$2.28 - $3.8 $13 - $22	-6 Closed	0 $0
Q4 2017 May 14, 2018	BUY	$2.28 - $6.71 $13 - $40	6	6 $0

248

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.44B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.